Back
Corporate News
Aptus Pharma plans to raise funds via preferential allotment, board to meet August 8
05-Aug-2026, 08:51
Aptus Pharma Limited will seek to raise funds through the issuance of equity shares and/or other eligible securities via a preferential allotment, according to a regulatory filing with the BSE Ltd on August 5, 2026. The company’s board of directors will consider and deliberate on the proposal during a meeting scheduled for August 8, 2026, and the trading window for company securities will be closed for designated persons and their immediate relatives from August 5, 2026, at 6:00 p.m. until 48 hours after the board meeting’s outcome is disseminated to the stock exchanges.
Aptus Pharma Limited will seek to raise funds through the issuance of equity shares and/or other eligible securities via a preferential allotment, according to a regulatory filing with the BSE Ltd on August 5, 2026. The company’s board of directors will consider and deliberate on the proposal during a meeting scheduled for August 8, 2026, and the trading window for company securities will be closed for designated persons and their immediate relatives from August 5, 2026, at 6:00 p.m. until 48 hours after the board meeting’s outcome is disseminated to the stock exchanges.